GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (OCSE:GUBRA) » Definitions » Interest Expense

Gubra AS (OCSE:GUBRA) Interest Expense : kr-4.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Gubra AS's interest expense for the six months ended in Dec. 2023 was kr -2.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was kr-4.9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Gubra AS's Operating Income for the six months ended in Dec. 2023 was kr -24.9 Mil. Gubra AS's Interest Expense for the six months ended in Dec. 2023 was kr -2.0 Mil. Gubra AS did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Gubra AS Interest Expense Historical Data

The historical data trend for Gubra AS's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Interest Expense Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
- -1.37 -1.69 -1.52 -4.89

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Expense Get a 7-Day Free Trial - -0.94 -0.58 -2.87 -2.02

Gubra AS Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-4.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gubra AS  (OCSE:GUBRA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gubra AS's Interest Expense for the six months ended in Dec. 2023 was kr-2.0 Mil. Its Operating Income for the six months ended in Dec. 2023 was kr-24.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was kr60.7 Mil.

Gubra AS's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Gubra AS did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Gubra AS (OCSE:GUBRA) Business Description

Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (OCSE:GUBRA) Headlines

No Headlines